177 related articles for article (PubMed ID: 35241838)
41. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
Si YJ; Guang LX; Yuan FH; Zhang KB
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
[TBL] [Abstract][Full Text] [Related]
42. Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant.
Qiao J; Black ME; Caruso M
Hum Gene Ther; 2000 Jul; 11(11):1569-76. PubMed ID: 10945770
[TBL] [Abstract][Full Text] [Related]
43. Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene.
Chalmers D; Ferrand C; Apperley JF; Melo JV; Ebeling S; Newton I; Duperrier A; Hagenbeek A; Garrett E; Tiberghien P; Garin M
Mol Ther; 2001 Aug; 4(2):146-8. PubMed ID: 11482986
[TBL] [Abstract][Full Text] [Related]
44. Liposomal encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats.
Engelmann C; Panis Y; Bolard J; Diquet B; Fabre M; Nagy H; Soubrane O; Houssin D; Klatzmann D
Hum Gene Ther; 1999 Jun; 10(9):1545-51. PubMed ID: 10395379
[TBL] [Abstract][Full Text] [Related]
45. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene.
Rosenfeld ME; Vickers SM; Raben D; Wang M; Sampson L; Feng M; Jaffee E; Curiel DT
Ann Surg; 1997 May; 225(5):609-18; discussion 618-20. PubMed ID: 9193188
[TBL] [Abstract][Full Text] [Related]
46. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
47. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
48. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.
Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T
Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379
[TBL] [Abstract][Full Text] [Related]
49. Combined antitumor gene therapy with herpes simplex virus-thymidine kinase and short hairpin RNA specific for mammalian target of rapamycin.
Woo HN; Lee WI; Kim JH; Ahn J; Han JH; Lim SY; Lee WW; Lee H
Int J Oncol; 2015 Dec; 47(6):2233-9. PubMed ID: 26459571
[TBL] [Abstract][Full Text] [Related]
50. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
51. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
[TBL] [Abstract][Full Text] [Related]
52. Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification.
Jiang YX; Lu Y; Liu TJ; Yang J; Chen Y; Fang YW
Mol Vis; 2011 Jan; 17():291-9. PubMed ID: 21283526
[TBL] [Abstract][Full Text] [Related]
53. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
[TBL] [Abstract][Full Text] [Related]
54. Conservative mutations of glutamine-125 in herpes simplex virus type 1 thymidine kinase result in a ganciclovir kinase with minimal deoxypyrimidine kinase activities.
Hinds TA; Compadre C; Hurlburt BK; Drake RR
Biochemistry; 2000 Apr; 39(14):4105-11. PubMed ID: 10747801
[TBL] [Abstract][Full Text] [Related]
55. Recombinant interferon alpha2a synergistically enhances ganciclovir-mediated tumor cell killing in the herpes simplex virus thymidine kinase system.
Whartenby KA; Darnowski JW; Freeman SM; Yurasha K; Calabresi P
Cancer Gene Ther; 1999; 6(5):402-8. PubMed ID: 10505850
[TBL] [Abstract][Full Text] [Related]
56. Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration.
Klatzmann D
Hum Gene Ther; 1996 Jan; 7(2):255-67. PubMed ID: 8788175
[TBL] [Abstract][Full Text] [Related]
57. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM
Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840
[TBL] [Abstract][Full Text] [Related]
58. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
Kokoris MS; Sabo P; Adman ET; Black ME
Gene Ther; 1999 Aug; 6(8):1415-26. PubMed ID: 10467366
[TBL] [Abstract][Full Text] [Related]
59. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
Konson A; Ben-Kasus T; Mahajna JA; Danon A; Rimon G; Agbaria R
Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
[TBL] [Abstract][Full Text] [Related]
60. Antitumor activity and metabolic activation of N-methanocarbathymidine, a novel thymidine analogue with a pseudosugar rigidly fixed in the northern conformation, in murine colon cancer cells expressing herpes simplex thymidine kinase.
Noy R; Ben-Zvi Z; Manor E; Candotti F; Morris JC; Ford H; Marquez VE; Johns DG; Agbaria R
Mol Cancer Ther; 2002 Jun; 1(8):585-93. PubMed ID: 12479218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
